Med BioGene

MBI-CA:TSX

Biotechnology

Market Cap

—

MICRO cap

Share Price ←

(—)

YTD Return ←

—

since start of 2020

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Biotechnology Founded 2006

Med BioGene, Inc. operates as a life science company, which engages in the development and commercialization of genomic-based clinical laboratory diagnostic tests. It focuses on managing the license and rights to GeneFx Lung, a proprietary gene expression-based test for early-stage non-small-cell lung cancer. The company was founded on April 28, 2006 and is headquartered in Vancouver, Canada.

website

Headquarters

598 East Kent Avenue South

Vancouver, BC V5X 4V6

1.604.732.8821

Executives

Name	Title	Gender
Iain Weir-Jones, PhD	Chairman & Chief Executive Officer	Male
Ibrahim Ghobrial	Chief Financial Officer	Male

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

— N/A

Med BioGene - Competitors and Related Companies

How Med BioGene stacks up to its peers in the Biotechnology industry or with competing business segments.